Omar K. Haffar, Ph.D. Founder, President & CEO
Cell Biologist with 33 years of experience in the Biotech/Pharmaceutical industry. Genentech (South San Francisco, CA), Bristol-Myers Squibb (Seattle, WA), Founder or co-Founder of 3 previous Biotech companies: Cytokine Networks, Inc., (Seattle, WA); International Therapeutics, Inc. (Seattle, WA); Presidio Pharmaceuticals, Inc. (San Francisco, CA). Dr. Haffar is the Chairman of the Board of Presidio Pharmaceuticals and Board member of Naia Limited. Dr. Haffar received his B.Sc. in Biology from the American University of Beirut (Beirut, Lebanon), his M.Sc. in Physiology from the University of Oregon (Eugene, OR), and his Ph.D. in Physiology/Anatomy from the University of California, Berkeley (Berkeley, CA)
Thomas P. Plotts, MBACFO
23 years of senior financial and operational experience in life-sciences, technology and equity capital markets. Formerly Vice President of Finance and CFO at Los Angeles Biomedical Research Institute (Torrance, CA), Nasdaq-listed Atrinsic, Inc. (New York, NY), Nasdaq-listed Cardiac Science Corp. (Irvine, CA) and Jefferies & Company (Los Angeles, CA). Experience in strategic planning and financial, planning and analysis, IPOs and secondary offerings, U.S. GAAP financials, SEC reporting and investor relations. Mr. Plotts received his M.B.A. from the Marshall School of Business at the University of Southern California (Los Angeles, CA)